Skip to main content
NVDA-1.58%GOOGL-0.53%AAPL-0.40%MSFT-0.51%AMZN-0.54%TSM-0.75%AVGO-0.73%TSLA-1.03%META-0.40%WMT-0.41%BRK-B+0.01%LLY0.00%MU-1.40%JPM-0.02%AMD-2.53%XOM-0.01%V-0.01%INTC-1.68%ASMLa+0.40%JNJ-0.02%ORCL+0.45%0700.HK0.00%COST0.00%CSCO0.00%MA+0.05%1398.HK-0.22%CAT+0.03%CVX+0.08%ABBV+0.04%NFLX-0.23%LRCX-0.05%BAC-0.01%0857.HK-0.27%KO+0.01%UNH-0.03%1816.HK-27.73%AMAT-0.06%AP2d+0.38%PG-0.27%9988.HK-0.08%HSBA.L+0.42%GE-0.02%BABA-0.14%MS+0.01%HD+0.02%0005.HK-0.26%PM+0.58%AZN+0.02%GS-0.06%NVS+0.01%GBPJPY+0.89%GBPCHF+0.85%GBPUSD+0.83%EURGBP-0.81%GBPAUD+0.79%GBPCAD+0.79%NZDJPY+0.58%NZDCHF+0.54%NZDUSD+0.51%EURNZD-0.50%AUDNZD-0.47%NZDCAD+0.47%GBPTRY+0.41%GBPHKD+0.32%GBPNZD+0.31%GBPMXN-0.28%USDTHB-0.26%USDTRY+0.20%USDCNH-0.19%USDILS+0.16%CADJPY+0.11%AUDJPY+0.11%EURJPY+0.08%CADCHF+0.07%USDJPY+0.07%SGDJPY-0.06%AUDCHF+0.06%USDMXN+0.05%CHFSGD+0.04%EURCHF+0.04%AUDUSD+0.04%USDCOP-0.04%USDZAR+0.03%EURCAD-0.03%USDHKD+0.03%EURSGD+0.03%GBPSGD+0.03%USDCAD-0.03%USDCHF+0.03%CHFJPY+0.02%NZDMXN+0.02%USDSGD+0.02%AUDSGD-0.02%EURUSD+0.01%NZDSGD+0.01%AUDCAD0.00%EURAUD0.00%AUDNOK0.00%AUDDKK0.00%PLNJPY0.00%EURSEK0.00%EURPLN0.00%EURNOK0.00%EURHKD0.00%EURDKK0.00%EURCZK0.00%GBPZAR0.00%NOKJPY0.00%EURCNH0.00%EURZAR0.00%CHFSEK0.00%CHFNOK0.00%USDDKK0.00%USDNOK0.00%USDPLN0.00%USDSEK0.00%GAGUSD-0.73%XAGUSD-0.71%USOIL-0.33%HG1-0.19%XPTUSD-0.18%GAUUSD-0.18%XAUUSD-0.18%XNGUSD+0.11%S10.00%W10.00%UKOIL0.00%C10.00%BTCUSD0.00%BTCUSDT+1.79%ETHUSD+0.06%USDTUSD-0.01%BNBUSD+0.01%BNBUSDT+2.96%XRPUSD+0.08%SOLUSD+0.20%TRXUSDT-0.01%DOGEUSD+0.18%ZECUSDT+0.18%ADAUSDT-0.02%ADAUSD+0.24%BCHUSDT-0.15%XMRUSDT+0.24%LINKUSD+0.06%XLMUSDT-17.70%TONUSD+0.92%XLMUSD+0.07%LTCUSD+0.17%SUIUSD+0.32%AVAXUSDT-1.29%AVAXUSD-0.17%HBARUSDT+0.04%SUIUSDT+12.51%TONUSDT+52.06%TAOUSDT+0.14%UNIUSD+0.18%NEARUSD-0.28%DOTUSDT+0.20%UNIUSDT+10.98%NEARUSDT+24.78%PEPEUSD+10018608.82%ETCUSD+0.17%ICPUSDT-0.06%AAVEUSD-0.20%ETCUSDT+6.48%ONDOUSDT-0.43%ATOMUSDT+0.03%JUPUSDT-0.47%WLDUSDT-0.64%ARBUSDT+0.17%PENGUUSDT+99546.65%INJUSDT+0.28%FETUSDT+0.13%STXUSDT+0.12%SEIUSDT-0.74%TIAUSDT+0.22%IMXUSDT-0.59%GRTUSDT-0.34%NVDA-1.58%GOOGL-0.53%AAPL-0.40%MSFT-0.51%AMZN-0.54%TSM-0.75%AVGO-0.73%TSLA-1.03%META-0.40%WMT-0.41%BRK-B+0.01%LLY0.00%MU-1.40%JPM-0.02%AMD-2.53%XOM-0.01%V-0.01%INTC-1.68%ASMLa+0.40%JNJ-0.02%ORCL+0.45%0700.HK0.00%COST0.00%CSCO0.00%MA+0.05%1398.HK-0.22%CAT+0.03%CVX+0.08%ABBV+0.04%NFLX-0.23%LRCX-0.05%BAC-0.01%0857.HK-0.27%KO+0.01%UNH-0.03%1816.HK-27.73%AMAT-0.06%AP2d+0.38%PG-0.27%9988.HK-0.08%HSBA.L+0.42%GE-0.02%BABA-0.14%MS+0.01%HD+0.02%0005.HK-0.26%PM+0.58%AZN+0.02%GS-0.06%NVS+0.01%GBPJPY+0.89%GBPCHF+0.85%GBPUSD+0.83%EURGBP-0.81%GBPAUD+0.79%GBPCAD+0.79%NZDJPY+0.58%NZDCHF+0.54%NZDUSD+0.51%EURNZD-0.50%AUDNZD-0.47%NZDCAD+0.47%GBPTRY+0.41%GBPHKD+0.32%GBPNZD+0.31%GBPMXN-0.28%USDTHB-0.26%USDTRY+0.20%USDCNH-0.19%USDILS+0.16%CADJPY+0.11%AUDJPY+0.11%EURJPY+0.08%CADCHF+0.07%USDJPY+0.07%SGDJPY-0.06%AUDCHF+0.06%USDMXN+0.05%CHFSGD+0.04%EURCHF+0.04%AUDUSD+0.04%USDCOP-0.04%USDZAR+0.03%EURCAD-0.03%USDHKD+0.03%EURSGD+0.03%GBPSGD+0.03%USDCAD-0.03%USDCHF+0.03%CHFJPY+0.02%NZDMXN+0.02%USDSGD+0.02%AUDSGD-0.02%EURUSD+0.01%NZDSGD+0.01%AUDCAD0.00%EURAUD0.00%AUDNOK0.00%AUDDKK0.00%PLNJPY0.00%EURSEK0.00%EURPLN0.00%EURNOK0.00%EURHKD0.00%EURDKK0.00%EURCZK0.00%GBPZAR0.00%NOKJPY0.00%EURCNH0.00%EURZAR0.00%CHFSEK0.00%CHFNOK0.00%USDDKK0.00%USDNOK0.00%USDPLN0.00%USDSEK0.00%GAGUSD-0.73%XAGUSD-0.71%USOIL-0.33%HG1-0.19%XPTUSD-0.18%GAUUSD-0.18%XAUUSD-0.18%XNGUSD+0.11%S10.00%W10.00%UKOIL0.00%C10.00%BTCUSD0.00%BTCUSDT+1.79%ETHUSD+0.06%USDTUSD-0.01%BNBUSD+0.01%BNBUSDT+2.96%XRPUSD+0.08%SOLUSD+0.20%TRXUSDT-0.01%DOGEUSD+0.18%ZECUSDT+0.18%ADAUSDT-0.02%ADAUSD+0.24%BCHUSDT-0.15%XMRUSDT+0.24%LINKUSD+0.06%XLMUSDT-17.70%TONUSD+0.92%XLMUSD+0.07%LTCUSD+0.17%SUIUSD+0.32%AVAXUSDT-1.29%AVAXUSD-0.17%HBARUSDT+0.04%SUIUSDT+12.51%TONUSDT+52.06%TAOUSDT+0.14%UNIUSD+0.18%NEARUSD-0.28%DOTUSDT+0.20%UNIUSDT+10.98%NEARUSDT+24.78%PEPEUSD+10018608.82%ETCUSD+0.17%ICPUSDT-0.06%AAVEUSD-0.20%ETCUSDT+6.48%ONDOUSDT-0.43%ATOMUSDT+0.03%JUPUSDT-0.47%WLDUSDT-0.64%ARBUSDT+0.17%PENGUUSDT+99546.65%INJUSDT+0.28%FETUSDT+0.13%STXUSDT+0.12%SEIUSDT-0.74%TIAUSDT+0.22%IMXUSDT-0.59%GRTUSDT-0.34%

AbbVie Inc. (ABBV)

NYSE • Healthcare

$212.28
-$1.47 (-0.7%)
Market closed

May 20, 2026 at 16:00 UTC

Interactive Chart

AB

22:24:23 UTC

About AbbVie Inc.

Name
AbbVie Inc.
CEO
Robert A. Michael
Website
www.abbvie.com
Industry
Healthcare
Year Founded
2011
Employees
55,000

AbbVie Inc. is a biopharmaceutical company that researches, develops, and markets therapies across immunology, oncology, neuroscience, and other therapeutic areas. The company is known for both specialty medicines and a pipeline of investigational drugs designed to address chronic and complex diseases. Its research strategy emphasizes biologics, small molecules, and targeted therapies supported by clinical trials and global partnerships. With worldwide operations, AbbVie integrates advanced science with commercial scale to deliver healthcare solutions. Positioned within the healthcare sector, the company reflects the growing role of biotechnology in modern medicine.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 15 Buy, 7 Hold, 2 Sell
Buy15
Hold7
Sell2

Fundamentals & Financials

Revenue (TTM)
$62.8B
Net Income (TTM)
$3.6B
EPS (TTM)
$2.04
ROA (TTM)
2.67%
Current Ratio
0.8
Dividend Yield
0.8%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ1 2026
Revenue$15,002M
Cost of Sales$2,470M
Gross Profit$12,532M
Operating Income$4,734M
Net Income$699,000K
EPS$0.39

Technical Indicators

AbbVie Inc.'s Technical Indicators Summary

ABBV shows constructive internals with price above its short- and medium-term moving averages, accompanied by bullish MACD and an elevated RSI consistent with buying interest, while VWAP and classic pivot lie below the market. Trend strength is modest rather than strong, but momentum and CCI readings reinforce the positive tilt and ATR indicates contained volatility. Volume measures give some support to the advance. Technical takeaway: the technical stance is bullish, as price sits above key averages and intraday benchmarks supporting the upside bias.

Buy
15 signals
Neutral
7 signals
Sell
2 signals
Overall: Bullish63% Bullish signals
IndicatorValue
RSI (14)
61.20
Stochastic %K (14, 3, 3)
84.89
CCI (20)
130.54
WPR (14)
-3.80
Momentum (10)
9.09
MFI
49.13
MACD Level (12, 26)
0.64
Bollinger Bands
$195.33 - $215.22
ATR (14)
$5.44 (2.53%)
ADX (14)
18.68
OBV
-4,618,056
VWAP
$213.51
Classic Pivot Point
$209.48
Fibonacci Pivot Point
$209.48
Simple Moving Averages
$205.28 - $209.09(5 indicators)
Exponential Moving Averages
$207.63 - $213.58(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The session wrapped with ABBV mildly under yesterday, as the -0.67% gap down left it closing around 212.32. Into the bell, ABBV's options showed a bearish bias, with the put/call ratio elevated to 1.00. ABBV edged lower as Humira erosion weighs on sentiment, even as Skyrizi and Rinvoq momentum supports the portfolio; options lean bearish.

Price Change

from $212.28 close

+$0.09

Trading Volume

Below avg (5.9M)

3M

vs S&P 500 Today

Underperforming Market

-2.49%

52-Week Position

Mid-range

49.7%

Updated: May 20, 2026 at 20:14 UTC

Quote Summary

OpenPrevious Close
$209.9$209.43
Day Range52 Week Range
$208.73 - $215.8$180.25 - $244.81
VolumeAvg. Volume
1.6M6.7M
Market CapP/E Ratio
$379.8B105.8

ABBV Headlines

View All ABBV Headlines

Peers & Related Assets

JNJJohnson & Johnson
$229.35+0.2%
UNHUnitedHealth Group
$391.88+0.2%
AZNAstraZeneca PLC
$185.7+0.9%
NVSNovartis AG
$150.73+1.1%
AMGNAmgen Inc.
$331.29+2.1%
GILDGilead Sciences, Inc.
$131.32+1.3%
PFEPfizer, Inc.
$25.68+1.4%